Mercury Laboratories Limited (BOM:538964)

India flag India · Delayed Price · Currency is INR
800.00
0.00 (0.00%)
At close: Jan 19, 2026
-8.05%
Market Cap939.60M
Revenue (ttm)773.75M
Net Income (ttm)49.14M
Shares Out1.20M
EPS (ttm)40.94
PE Ratio19.13
Forward PEn/a
Dividend3.50 (0.45%)
Ex-Dividend DateAug 6, 2025
Volume96
Average Volume93
Open800.00
Previous Close800.00
Day's Range800.00 - 800.00
52-Week Range736.00 - 976.00
Beta0.42
RSI36.95
Earnings DateFeb 11, 2026

About Mercury Laboratories

Mercury Laboratories Limited engages in manufacturing, selling, exporting, and dealing in various pharmaceutical drugs and medicines for mother and child healthcare in India and internationally. The company offers analgesic, anti-inflammatory, anti-pyretic, anthelmintic, antibiotic, anti-coagulant, anti-platelet, bleeding agent, anti-fungal, anti-hypertensive, anti-malarial, cardiovascular system, central nervous system, eye, gastro-intestinal system, hypoglycemic/anti-diabetic, multivitamin, protein supplement, respiratory system, anti-allergi... [Read more]

Industry Pharmaceutical Preparations
Founded 1962
Employees 503
Stock Exchange Bombay Stock Exchange
Ticker Symbol 538964
Full Company Profile

Financial Performance

In 2024, Mercury Laboratories's revenue was 751.01 million, a decrease of -0.61% compared to the previous year's 755.59 million. Earnings were 31.45 million, a decrease of -44.38%.

Financial Statements